US Pharma MarketingNovo salvages happy ending for scrapped Parkinson’s cell therapy via deal with AI biotech
Novo salvages happy ending for scrapped Parkinson’s cell therapy via deal with AI biotech is a pharma and life sciences industry update from FierceBiotech. The story may affect commercial strategy, market access planning, stakeholder engagement, competitive positioning, and near-term monitoring for pharmaceutical and biotech teams.
Novo Nordisk has found the latest buyer for one of its orphaned cell therapies.
Source: FierceBiotech